Q-omics provides the consensus-scored SNORA73A profile across patient tissues and cancer cell-line models. Additionally, SNORA73A mutation status shows 29 significant gene co-expression associations, with the highest sampling consensus in SKCM.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORA73A — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORA73A in patient tissues and cancer cell lines. In patient samples, SNORA73A shows the broadest associations at the RNA and protein expression levels, with SKCM recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Mutation
RNA	29	SKCM (18)	view →
▼RNA
Drug	1	PEMB_ALL (1)	view →